Hello and Welcome to Patientsville.com, Your Source for all GLIBENCLAMIDE information. We are dedicated to provide You with GLIBENCLAMIDE safety information. Learn about GLIBENCLAMIDE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
GLIBENCLAMIDE Safety Reports
Total GLIBENCLAMIDE reports: 3.GLIBENCLAMIDE FDA safety alerts: No.
Reported hospitalizations: 1.
Take GLIBENCLAMIDE Side Effects Survey or Share Your GLIBENCLAMIDE Story. Read More Here.
Health Professional from UNITED STATES reported GLIBENCLAMIDE problem on May 05, 2003. Male patient, 41 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, schizoaffective disorder and was treated with GLIBENCLAMIDE. After drug was administered, patient experienced the following problems/side effects: anxiety, confusional state, derealisation, fatigue, fear, hypoglycaemia, loss of consciousness, major depression. GLIBENCLAMIDE dosage: 1.25 MG, BID;. During the same period patient was treated with SERTRALINE, RISPERIDONE, BENZTROPEINE, FUROSEMIDE. Patient recovered.
GLIBENCLAMIDE problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on May 02, 2007. Male patient, 77 years of age, was treated with GLIBENCLAMIDE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, hypoglycaemia. GLIBENCLAMIDE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from SPAIN reported GLIBENCLAMIDE problem on June 22, 2007. Female patient was treated with GLIBENCLAMIDE. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, syncope. GLIBENCLAMIDE dosage: unknown. During the same period patient was treated with ENALAPRIL. Patient recovered.